Inventurus Knowledge Solutions IPO: Rekha Jhunjhunwala-Backed Issue's GMP Hints Strong Listing; Check

The Inventurus Knowledge Solutions (IKS) IPO has opened for subscription, running from December 12 to December 16, 2024. Aiming to raise approximately Rs 2,497.92 crore, the book-built issue comprises a fresh issue component alongside an offer-for-sale (OFS) of up to 1.87 crore equity shares with a face value of Rs 1 each.

Inventurus Knowledge Solutions IPO GMP
The grey market premium (GMP) for the IKS IPO currently stands at Rs 405 per share. This suggests an estimated listing price of Rs 1,734 per share, translating to a potential gain of 30.47% over the upper price band of Rs 1,329. The GMP highlights strong investor sentiment, further boosted by backing from prominent investor Rekha Jhunjhunwala.

Subscription Status
The subscription figures for the IKS IPO showcase a strong response from various investor categories. The Retail Individual Investors (RIIs) segment was subscribed 4.24 times, while the non-institutional investors (NII) category saw a subscription of 3.13 times. Qualified Institutional Buyers (QIBs) also exhibited notable interest, with a subscription rate of 1.89 times.

IPO Details
The Inventurus Knowledge Solutions IPO is priced within a band of Rs 1,265 to Rs 1,329 per share. The allocation is structured to cater to diverse investor groups, with 75% reserved for QIBs, 15% for High Net-Worth Individuals (HNIs), and 10% for retail investors. Post-allotment, the shares are set to list on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on December 19, 2024. Allotments will be finalized by December 17.

About The Company
Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a provider of healthcare technology solutions designed to streamline administrative processes for healthcare providers. The company specializes in medical documentation management, virtual medical scribing, and clinical support, significantly reducing the administrative burden on healthcare professionals.

IKS revenue has surged to Rs 1,817.93 crore in FY 2024, up from Rs 1,031.30 crore in FY 2023. Similarly, net profit rose from Rs 305.23 crore in FY 2023 to Rs 370.49 crore in FY 2024.

Promoters
The company's promoter group includes notable names such as Sachin Gupta, Rekha Jhunjhunwala, Aryaman Jhunjhunwala Discretionary Trust, Aryavir Jhunjhunwala Discretionary Trust, and Nishtha Jhunjhunwala Discretionary Trust. Backing from Rekha Jhunjhunwala, a well-known investor, has further enhanced the IPO's credibility.

GMP & Subscription Trends
The strong grey market premium and positive subscription trends point toward a successful IPO listing. With an estimated listing price of Rs 1,734 based on the current GMP, IKS shares are poised to debut at a premium.